Results 121 to 130 of about 110,187 (167)

Telomere-driven dysfunctional changes in gynecological cancers: mechanistic insights, biomarker potential, and therapeutic targeting. [PDF]

Front Cell Dev Biol
Afolabi OA, Alade TA, Olaniyi KS, Adeyemi MO, Oladepo S, Gbadero JO, Oyedokun MD, Olayemi SB, Akindele BM, Oladipo AA, Adegbola CA, Oghenetega OB, Akinsanya SY, Sotunsa J, Ogunleye OD, Lasisi-Sholola AS, Owolabi VP, Adewale O, Adewale J, Oke DA, Adelani Abdur-Rahman H, Oyedokun PA.   +21 more
europepmc   +1 more source

Indications and Efficacy of Progestogen‐Monotherapy as Menopause Hormone Therapy: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen monotherapy, though historically underutilized, represents a viable alternative in this population. This narrative review
Chloe Thomas, Olivia Carere, Lauren Clarfield, Michelle Jacobson   +3 more
wiley   +1 more source

Associations of novel adiposity indices with gynecological cancer risk among adult women: Evidence from NHANES 2011 to 2018. [PDF]

Medicine (Baltimore)
Huang W, Jin X.
europepmc   +1 more source

Systemic Therapy Management Strategies for Early‐Stage Breast Cancer in Australia

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Advances in systemic therapy for early‐stage breast cancer in Australia highlight genomic‐guided decisions, subtype‐specific strategies, and emerging targeted and immunotherapies, shaping personalized and de‐escalated treatment approaches. ABSTRACT Breast cancer is the most common cancer among Australian women, with early‐stage disease (Stages I, II ...
Nicholas Zdenkowski, Rachel Dear, Sanjeev Kumar, Hilary Martin, Dhanusha Sabanathan, Stephen J. Luen, Belinda Yeo   +6 more
wiley   +1 more source

Expression and clinical significance of cytochrome b561 in endometrial cancer. [PDF]

J Cancer Res Clin Oncol
Lei H, Liao H, An Z, Li X, Li X, Hu J, Zhou X.   +6 more
europepmc   +1 more source

Oncology Inpatient Resuscitation Planning and Long‐Term “Rapid Response Call” Outcomes

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Optimal end‐of‐life care involves a patient‐centered approach. The dual audits presented in this study show that a proportion of oncology patients receiving palliative‐intent cancer treatment continue to be managed in hospital without a resuscitation plan and may undergo care escalation to a “rapid response” intervention despite poor prognosis ...
Dhanashree Tikhe, Petition Nhira, Megan Kepreotis, Fiona Day   +3 more
wiley   +1 more source

Integrated multi-omics and machine learning highlight PTM-related genes as potential biomarkers in endometrial cancer. [PDF]

Transl Oncol
Zhou X.
europepmc   +1 more source

Cadaveric addendum to the consensus on ultrasound‐based lymph‐node staging in gynecological cancer

Ultrasound in Obstetrics &Gynecology, EarlyView.
D. Fischerova, E. Farsi, E. Facchetti, E. Panizzolo, G. Gambino, H. Reina, F. Sousa, M. R. Kadajari, N. Tiszlavicz, G. Garganese, O. Nanka, Collaborators, E. Gatti, C. Culcasi   +13 more
wiley   +1 more source

Efficacy and Safety of Dupilumab in Chinese Adult Patients With Chronic Rhinosinusitis With Nasal Polyps: A Randomized, Placebo‐Controlled, Phase III Trial

Allergy, EarlyView.
Dupilumab significantly improved nasal polyp score, nasal congestion, olfaction, total symptom score, and disease‐specific quality of life in Chinese patients with uncontrolled CRSwNP. Incidence of treatment‐emergent adverse events was similar between dupilumab and placebo.
Mu Xian, Menglin Wang, Changqing Zhao, Lijia Wan, Yu Xu, Juan Meng, Rui Xu, Xicheng Song, Li Shi, Yucheng Yang, Yan Jiang, Yanzhen Wu, Bethany Ling, Vivian Li, Andrew P. Fontenot, Lacey R. Robinson, Neelam A. Phadke, Chengshuo Wang, Luo Zhang   +18 more
wiley   +1 more source